No difference in adherence to paroxetine between depressed patients with early remission and those with late remission based on monitoring of plasma paroxetine concentrations

Human Psychopharmacology

Volumn 25, Issue 6, 2010, Pages 487-490

  Yoshimura, Reiji ^a   Umene Nakano, Wakako ^a   Ueda, Nobuhisa ^a   Ikenouchi Sugita, Atsuko ^a   Hori, Hikaru ^a   Katsuki, Asuka ^a   Hayashi, Kenji ^a   Miyamoto, Kyoko ^a   Kodama, Yuki ^a   Nakamura, Jun ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Adherence; Depression; Paroxetine; Plasma; Remission

Indexed keywords

PAROXETINE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE DURATION; DRUG BLOOD LEVEL; DRUG MONITORING; FEMALE; HOSPITAL DISCHARGE; HUMAN; MAJOR DEPRESSION; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; REMISSION; TREATMENT DURATION;

ADULT; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INPATIENTS; MALE; MEDICATION ADHERENCE; PAROXETINE; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 77956585650     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1136     Document Type: Article

References (19)

1. Aukst-Margetic B, Margetic B. 2005. An open-label series using loratadine for the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors. Prog Neuropsychopharmacol Biol Psychiatry 29: 754-756. (Pubitemid 40897788)
2. Basco MR, Rush JA. 1995. Compliance with pharmacotherapy in mood disorders. Psychiatr Ann 25: 269-279.
3. Bauer M, Glenn T, Grof P, et al. 2010. The association between concurrent psychotropic medications and self-reported adherence with taking a mood stabilizer in bipolar disorder. Hum Psychopharmacol 25: 47-54.
4. Berk L, Hallam KT, Colom F, et al. 2010. Enhancing medication adherence in patients with bipolar disorder. Hum Psychopharmacol 25: 1-16.
5. Cantrell CR, Eaddy MT, Shah MB, Regan TS, Sokol MC. 2006. Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes. Med Care 44: 300-303.
6. Cramer JA. 1991. Medication compliance in epilepsy. Arch Intern Med 151: 1236-1237.
7. First MB, Spitzer RL, Gibbon M, Williams JBW. 1995. Structured Clinical Interview for DSM-IV Axis I Disorders, Patients Edition (SCID-P), Version 2. New York State Psychiatric Institute, Biometrics Research, New York.
8. Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
9. Johnson DAW. 1981. Depression: treatment compliance in general practice. Acta Psychiatr Scand 63(Suppl 290): 447-453. (Pubitemid 11156137)
10. Karasu TB, Gelenberg A, Merriam A. 2000. Practice Guideline for the Treatment of Patients With Major Depressive Disorder, 2nd edn. American Psychiatric Association: Washington, DC.
11. Lin EHB, Von Korff M, Katon W. 1995. The role of the primary care physician in patient's adherence to antidepressant therapy. Med Care 33: 67-74.
12. Lingman R, Scott J. 2002. Treatment non-adherence in affective disorders. Acta Psychiatr Scand 105: 164-172.
13. Miyamoto K, Yoshimura R, Ueda N, Sugita A, Umene W, Hori H. 2007. Effects of acute paroxetine treatment on the consumption of cigarette smoking and caffeine in depressed patients. Hum Psychopharmacol 22: 483-490. (Pubitemid 47611304)
14. Sheehan D, Eaddy M, Sarnes M. 2004. Evaluating the economic consequences of early antidepressant treatment discontinuation. J Clin Psychopharmacol 24: 544-548.
15. Thompson D, Buesching D, Gregor KJ. 1996. Patterns of antidepressant use and their relations to cost of care. Am J Manag Care 2: 1239-1246. (Pubitemid 126477345)
16. Vaswani M, Linda FK, Ramesh S. 2003. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry 27: 85-102. (Pubitemid 36131110)
17. Yoshimura R, Mitoma M, Sugita A, et al. 2007. Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 31: 1034-1037. (Pubitemid 46824019)
18. Yoshimura R, Ikenouchi-Sugita A, Umene-Nakano W, et al. 2010a. Nonadherence to paroxetine: a study based on monitoring plasma paroxetine levels. J Clin Psychopharmacol 30: 82-83.
19. Yoshimura R, Ikenouchi-Sugita A, Hori H, et al. 2010b. Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression. Prog Neuropsychopharmacol Biol Psychiatry 34: 308-312.